Diseases & Disorders
(G30)
IRS Verified
DX Registered
INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH
CharityAI™ Score
Not yet evaluated
Mission Statement
IMBCR is the only independent non-profit cancer research institute dedicated to finding improved treatment and ultimately a cure for myeloma and bone cancer. Multiple myeloma is a cancer of malignant blood cells found in the bone marrow and we also conduct research into cancers that find their way into bones that also include breast, lung, and prostate.
Financial Overview — FY 2023
$1.1M
Total Revenue
$1.3M
Total Expenses
N/A
Net Assets
5
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$0
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.1M | $1.3M | N/A | — | 5 |
| 2022 | $2.3M | $1.5M | N/A | — | 7 |
| 2021 | $1.4M | $2.7M | N/A | — | 7 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.